Remus Pharmaceuticals Ltd

NSE: REMUS · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹855.00
Market cap: ₹1,008 Cr
Revenue (annual): ₹853.6 Cr
Net profit (annual): ₹36.99 Cr
P/E (TTM): 27.2×Sector 47.4×
Promoter holding: 70.95%
FII holding: 5.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Earnings Call 3 Management Change 2 Financial Results 2 Dividend 2 SME to Main Board Migration 1 Results Update 1 Merger & Restructuring 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

20 May 2026 15:15 IST NSE

Financial Results

Remus Pharmaceuticals H2 FY26 Results: Net Profit ₹24.6 Cr, Up 19.4% YoY

Remus Pharmaceuticals Ltd reported revenue from operations of ₹453.4 Cr (+30.4% YoY) and net profit of ₹24.6 Cr (+19.4% YoY) for H2 FY26.

Key figure: Net profit ₹24.6 Cr · +19.4% YoY

Open full results → Read the filing ↗

20 May 2026 15:14 IST NSE

Financial Results

Remus Pharmaceuticals Financial Results

Remus Pharmaceuticals reported FY26 consolidated revenue of ₹853.63 Crore and PAT of ₹46.17 Crore. The board recommended a final dividend of ₹0.50 per share.

Value: ₹0.59 Cr

Read the filing ↗